Sanofi Consumer Healthcare India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi Consumer Healthcare India has informed the stock exchanges that its trading window will remain closed from 1st July 2025 until 48 hours after the announcement of unaudited standalone financial results for the quarter ended 30th June 2025 (Q1 FY26). The closure is in line with the company's insider trading code and SEBI regulations to prevent trading by designated persons while results are being finalized. Designated employees and insiders are prohibited from dealing in the company's shares during this period.
This is a routine compliance disclosure with no direct impact on shareholders or stock price. Investors should note that quarterly results are expected to be announced soon after the window reopens, which could be a near-term catalyst to watch.